EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CXCL10-LACTC1/C2 Expressing Mesenchymal Stem Cell Conditioned Medium Attenuates TNF-α-Induced Gene Expressions and Cell Viability in HUVECs

Kaya Molo, Ruken Ege, Kübra Ati̇k, Elif Çıtak, Orçun Çulcuoğlu, Hakan Darıcı, Emel Ordu

Inflammation · 22.05.2026 · 49 (1)

DOI: 10.1007/s10753-026-02518-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, online erschienen am 22.05.2026. Verfasst von Kaya Molo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science and Letters, Department of Molecular Biology and Genetics, Yıldız Technical University, Istanbul, 34220, Turkey. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Chemokine CXCL10, Tumor Necrosis Factor-alpha, Human Umbilical Vein Endothelial Cells. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yıldız Technical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infectious diseases exacerbate atherosclerosis-associated morbidity and mortality by inducing sustained inflammatory responses characterized by elevated IL-6, TNF-α, IFN-γ, and CXCL10. Persistent CXCL10-driven recruitment of CXCR3⁺ immune cells promotes endothelial dysfunction and atherosclerotic progression. Although mesenchymal stem cells (MSCs) respond to inflammatory cues and secrete CXCL10, the contribution of CXCL10/CXCR3 signaling to intrinsic MSC immunomodulatory programming remains poorly understood. The objective of this study is to investigate whether CXCL10 signaling can modulate MSC-mediated immunoregulation. To address this, Wharton’s jelly–derived MSCs (WJ-MSCs) were genetically engineered to express a membrane-anchored CXCL10–Lactadherin C1/C2 fusion protein (CXCL10-LACTC1/C2). This strategy was designed to recapitulate physiological, localized, and sustained CXCL10 signaling, enabling spatially restricted chemokine presentation that more closely mimics cell-associated CXCL10 in inflammatory microenvironments compared with soluble CXCL10. The Lactadherin C1/C2 domain was selected to achieve stable, physiological membrane anchoring without introducing artificial transmembrane domains or compromising CXCL10 bioactivity. CXCL10-LACTC1/C2–expressing MSCs exhibited increased expression of key immunoregulatory mediators, including IDO1, TGF-β1, and IL4I1. Furthermore, conditioned medium derived from these MSCs attenuated TNF-α–induced inflammatory responses in human umbilical vein endothelial cells (HUVECs), as indicated by the modulation of endothelial activation and homeostasis markers (ICAM-1, PECAM-1, KDR, vWF, and NRF2) and improvement of cell viability. Collectively, these findings provide mechanistic insight into CXCL10-mediated MSC immunoregulation and support further investigation of MSC-based and cell-free therapeutic strategies aimed at mitigating CXCL10-driven endothelial inflammation in infection-associated vascular injury and atherosclerotic disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsChemokine CXCL10Tumor Necrosis Factor-alphaHuman Umbilical Vein Endothelial CellsHumansCulture Media, ConditionedCell SurvivalCells, CulturedGene ExpressionSignal Transduction

Stichwörter der Autor:innen

CXCL10Conditioned MediumGenetically Modified MSCsImmunomodulationInflammation

Substanzen

Chemokine CXCL10Tumor Necrosis Factor-alphaCulture Media, ConditionedCXCL10 protein, human

Autor:innen und Institutionen

  • Faculty of Science and Letters, Department of Molecular Biology and Genetics, Yıldız Technical University, Istanbul, 34220, Turkey.
  • Tissuecare Biotechnology, Istanbul, 34010, Turkey.
  • Faculty of Medicine, Department of Histology and Embryology, Istinye University, Istanbul, 34010, Turkey.
  • Stem Cell and Tissue Engineering R&D Center, Istinye University, Istanbul, 34010, Turkey.
  • Faculty of Science and Letters, Department of Molecular Biology and Genetics, Yıldız Technical University, Istanbul, 34220, Turkey. bemel@yildiz.edu.tr.

Förderung

  • Yıldız Technical University

Zitieren

APA

Molo, K., Ege, R., Ati̇k, K., Çıtak, E., Çulcuoğlu, O., Darıcı, H., & Ordu, E. (2026). CXCL10-LACTC1/C2 Expressing Mesenchymal Stem Cell Conditioned Medium Attenuates TNF-α-Induced Gene Expressions and Cell Viability in HUVECs. Inflammation, 49(1). https://doi.org/10.1007/s10753-026-02518-2

Vancouver

Molo K, Ege R, Ati̇k K, Çıtak E, Çulcuoğlu O, Darıcı H, et al. CXCL10-LACTC1/C2 Expressing Mesenchymal Stem Cell Conditioned Medium Attenuates TNF-α-Induced Gene Expressions and Cell Viability in HUVECs. Inflammation. 2026;49(1). doi:10.1007/s10753-026-02518-2

BibTeX
@article{Molo2026,
  author = {Molo, Kaya and Ege, Ruken and Ati̇k, Kübra and Çıtak, Elif and Çulcuoğlu, Orçun and Darıcı, Hakan and Ordu, Emel},
  title = {CXCL10-LACTC1/C2 Expressing Mesenchymal Stem Cell Conditioned Medium Attenuates TNF-α-Induced Gene Expressions and Cell Viability in HUVECs},
  journal = {Inflammation},
  year = {2026},
  volume = {49},
  number = {1},
  doi = {10.1007/s10753-026-02518-2}
}
Kostenlos starten →